Multi-center evaluation of Neurophet AQUA for brain MRI segmentation: T1 compared with FreeSurfer and T2-FLAIR compared with ground truth
Neurophet AQUA demonstrated high segmentation accuracy and excellent repeatability in rescanned measurements, as well as exploratory evidence of inter-scanner reproducibility on T1-weighted MRI, showing comparable performance to established tools such as FreeSurfer. It also showed consistent WMH segmentation across FLAIR types. Neurophet AQUA is highly suitable for clinical applications that require accurate analysis, high repeatability and reproducibility, and rapid brain MRI processing, making it particularly well-suited for multicenter research studies.
Institutions
- Harvard University (US)
- University of Basel (CH)
- Massachusetts General Hospital (US)
- Department of Biomedicine Basel (CH)
- Neurology, Inc (US)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.3389/fneur.2025.1672133
- Primary Topic
- Brain Tumor Detection and Classification
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alzheimer's Disease Neuroimaging Initiative